Manuela Milani

2.3k total citations
37 papers, 1.8k citations indexed

About

Manuela Milani is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Manuela Milani has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Manuela Milani's work include Cancer, Hypoxia, and Metabolism (7 papers), Estrogen and related hormone effects (5 papers) and Breast Cancer Treatment Studies (5 papers). Manuela Milani is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Estrogen and related hormone effects (5 papers) and Breast Cancer Treatment Studies (5 papers). Manuela Milani collaborates with scholars based in Italy, United Kingdom and United States. Manuela Milani's co-authors include Adrian L. Harris, Daniele Generali, Alberto Bottini, Tomasz Rzymski, Giovanni Allevi, Sergio Aguggini, Simone Bonardi, Stephen B. Fox, Luigi Dogliotti and Alessandra Bersiga and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Manuela Milani

35 papers receiving 1.7k citations

Peers

Manuela Milani
Comparison fields: 5 of 117
  • Molecular Biology 857
  • Cancer Research 714
  • Oncology 658
  • Epidemiology 364
  • Cell Biology 296
Peter Horak Germany
Zhengsheng Wu China
Lo‐Kong Chan Hong Kong
Susan Mason United Kingdom
Annan Yang United States
Daniela Califano Italy
Xiangpeng Dai United States
Michel Nofal United States
Dayana B. Rivadeneira United States
Antonella Papa United States
Peter Horak Germany View profile →
Citations per field, relative to Manuela Milani
Manuela Milani · 1×
Citations per year, relative to Manuela Milani
Manuela Milani · 1×

Countries citing papers authored by Manuela Milani

Since Specialization
Citations

This map shows the geographic impact of Manuela Milani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Milani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Milani more than expected).

Fields of papers citing papers by Manuela Milani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Milani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Milani. The network helps show where Manuela Milani may publish in the future.

Co-authorship network of co-authors of Manuela Milani

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Milani. A scholar is included among the top collaborators of Manuela Milani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Milani. Manuela Milani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study The Breast Francesco Schettini, Silvana Saracchini et al. 1
2 Computational reactive–diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib Scientific Reports Francesco Schettini, Maria Valeria De Bonis et al. 0
3 Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study European Journal of Cancer Francesco Schettini, Alessandra Fontana et al. 9
4 Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study Breast Cancer Research and Treatment Francesco Schettini, Navid Sobhani et al. 12
5 Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis The Lancet Oncology Mario Giuliano, Francesco Schettini et al. 119
6 Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR Journal of Cancer Research and Clinical Oncology Daniele Generali, Silvia Paola Corona et al. 3
7 A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers Clinical Breast Cancer Giandomenico Roviello, Manuela Milani et al. 4
8 Breast cancer circulating biomarkers: advantages, drawbacks, and new insights Tumor Biology Andrea Ravelli, James M. Reuben et al. 35
9 Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity Expert Review of Anticancer Therapy Andrea Ravelli, James M. Reuben et al. 11
10 ORGANISATION AND MANAGEMENT OF A COMPLETE BACHELOR DEGREE OFFERED ONLINE AT THE UNIVERSITY OF MILAN FOR TEN YEARS International Association for Development of the Information Society Manuela Milani et al. 4
11 Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability Cancer Research Isabel M. Pires, Zuzana Bencokova et al. 155
12 Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients Breast Cancer Research and Treatment Daniele Generali, Stephen B. Fox et al. 12
13 Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients Clinical Cancer Research Daniele Generali, Gaynor J. Bates et al. 129
14 The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib Cancer Research Manuela Milani, Tomasz Rzymski et al. 255
15 Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3 Radiotherapy and Oncology Hilda Mujčić, Tomasz Rzymski et al. 77
16 Cultural Impact on Online Education Quality Perception. The Electronic Journal of e-Learning Manuela Milani 12
17 Targeting tumour hypoxia in breast cancer European Journal of Cancer Manuela Milani, Adrian L. Harris 58
18 Cultural Differences in Academic Online Courses Quality Perception and Assessment EdMedia: World Conference on Educational Media and Technology Manuela Milani 3
19 Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer Endocrine Related Cancer Daniele Generali, Stephen B. Fox et al. 66
20 Modifications of Abdominal Fat and Hepatic Insulin Clearance during Severe Caloric Restriction Annals of Nutrition and Metabolism Ottavio Bosello, Mauro Zamboni et al. 21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026